Please login to the form below

allergy

This page shows the latest allergy news and features for those working in and with pharma, biotech and healthcare.

Moderna’s coronavirus vaccine hits first objectives

Shares in the US biotech spiked around 23% after the data emerged from the study, which was led by scientists at the US National Institute of Allergy and Infectious Diseases (NIAID).

Latest news

New study identifies drugs that are safe to use in COVID-19 treatment

Current evidence suggests that low dose prednisolone (a steroid used to treat allergies) and tacrolimus therapy (an immunosuppressive drug given to patients who have had an organ transplant) may have beneficial
FDA knocks back DBV’s peanut allergy therapy once again

drug. Like Palforzia, the rationale for Viaskin Peanut is to expose people with peanut allergy to small amounts of antigen over time to encourage the immune system to develop tolerance. ... reactions. Around one in five children diagnosed with the
US Department of Health and Human Services calls for coronavirus product proposals

The first batch of Moderna’s vaccine was sent to the NIH and the National Institute of Allergy and Infectious Diseases (NIAID) for testing in a planned phase 1 study.
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

Participants in the study, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), must have a laboratory-confirmed case of novel coronavirus – also known as COVID-19 –
Moderna and GSK advance coronavirus vaccine candidates

The vaccine has been sent to the National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH) to be used in a planned phase 1 study in

More from news
Approximately 16 fully matching, plus 194 partially matching documents found.

Latest Intelligence

As COVID-19 takes over the world, biopharma fights back

I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID).
Cortellis Drugs to Watch in 2020 report

This year’s list also highlights three first-in class medicines compared with last year’s list, which contained only one first-in-class medicine, peanut allergy vaccine Palforzia.
The long and winding road to asthma breakthroughs

The high unmet need was reinforced by a report issued in October by the European Federation of Allergy and Airways Diseases’ Patients’ Associations (EFA), which revealed there were 30 million children
Integrating patient reported outcomes into clinical trials

Aimmune Therapeutics prepared for commercialisation by using two PRO scales to show the effect of its peanut allergy drug on people’s emotions and social lives.
Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

Forecast sales for Skyrizi in 2023 are $1.74bn. AR-101 from Aimmune Therapeutics addresses peanut allergy.

More from intelligence
Approximately 1 fully matching, plus 22 partially matching documents found.

Latest appointments

New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

Before AstraZeneca, she worked for GlaxoSmithKline for four years in a number of roles, including therapy specialist for its allergy portfolio.
ALK-Abello appoints Søren Jelert as CFO

He will be based at the company’s headquarters in Denmark. Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees ... to become a truly global allergy company.”.
Cytovation expands management team

Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.
Lars Dreiøe joins Sobi in senior quality and compliance role

He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.
ARC names chairman and member of the board

ARC is a privately held biopharma company developing desensitisation treatments for food allergies. ... Iwicki said: “ARC is working to address a very compelling therapeutic area and provide an option to those dealing with food allergies.

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

Wilmington Healthcare appoints new consultants

for its allergy portfolio.
Corporate event food. How to get it right

Vegetarian. Vegan. Gluten-free. Peanut allergies. Lactose intolerant. Diabetic. Kosher. Halal. To keep everyone happy, be sure to ask your delegates if they have any dietary requirements ASAP.
Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments

Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment. ... This is not an isolated incident, but a constant fear and source of anxiety for allergy sufferers all over the
Atopic Dermatitis — Going Beyond the Pill

The majority of patients start to experience symptoms before they reach 5 years of age and often suffer from asthma or other allergies.
Barber shops provide a short cut to BP reduction

Allergy testing in flower shops? Why not? All it requires is localised expertise, and a government that is keen to devolve the complexity and cost of healthcare, which the NHS is